.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Federal Trade Commission
Queensland Health
Cipla
Accenture
McKesson
Colorcon
Deloitte
Dow
Cerilliant

Generated: December 16, 2017

DrugPatentWatch Database Preview

Chymotrypsin - Generic Drug Details

« Back to Dashboard

What are the generic sources for chymotrypsin and what is the scope of chymotrypsin freedom to operate?

Chymotrypsin
is the generic ingredient in three branded drugs marketed by Sola Barnes Hind, Ciba, Novartis, and Alcon, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for chymotrypsin.

Summary for chymotrypsin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
CibaCATARASEchymotrypsinFOR SOLUTION;OPHTHALMIC016938-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
NovartisCATARASEchymotrypsinFOR SOLUTION;OPHTHALMIC018121-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sola Barnes HindALPHA CHYMARchymotrypsinFOR SOLUTION;OPHTHALMIC011837-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
AlconZOLYSEchymotrypsinFOR SOLUTION;OPHTHALMIC011903-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Dow
Cerilliant
Merck
Moodys
Chubb
Baxter
Farmers Insurance
UBS
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot